Scientists discover key event in prostate cancer progression
... 24, 2009, issue of the journal Cell , focuses on androgen receptors, molecules located in the nucleus of ... that in androgen-independent prostate cancer, androgen receptors are reprogrammed to regulate a group of ... "Some late-phase prostate cancer does not require androgen hormones for tumor growth, but it does ...UT Southwestern researcher named HHMI Early Career Physician-Scientist
... of cancer death in men becomes resistant to androgen deprivation therapy. The most well-known androgen is the male sex hormone testosterone. Although prostate cancer initially responds to androgen withdrawal, these tumors eventually become ...Protein that suppresses androgen receptors could improve prostate cancer diagnosis, treatment
... Ga. A protein that helps regulate expression of androgen receptors could prove a new focal point for ... cells while expression of testosterone-fed androgen receptors is higher, they report in Proceedings ... this week. "An increase in the number of androgen receptors is believed responsible for prostate ...Prostate cancer therapy increases risk of fractures and cardiovascular-related death
... that decrease testosterone levelscalled androgen deprivation therapy (ADT)are important and ... mortality are low among men treated with androgen deprivation therapy, preventive treatments may ... risk of these serious adverse outcomes related to androgen deprivation therapy," the authors wrote. They ...Drug shows activity in men with advanced prostate cancer
... tumor growth. Many of these drugs disrupt the androgen (male hormone) receptor, which helps regulate ... that CRPC cells have increased expression of the androgen receptor and that overexpression of this receptor ... mouse models engineered to highly express the androgen receptor, mimic progression to ...A potential new target for treatment of hormone refractory prostate cancer
... new study identifies a protein that modifies the androgen receptor (AR) and influences its ability to ... recurrent cancers, which no longer respond to androgen blockade and are resistant to current therapy." ... prostate cancer tissues that do not respond to androgen ablation and is required for prostate tumor ...Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
... investigate the use of degarelix for intermittent androgen deprivation therapy (IADT) in patients with ... The study will compare IADT to continuous androgen deprivation therapy (ADT) for 14 months with ... measured by PSA suppression. "Intermittent androgen deprivation therapy is a commonly employed ...AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
... and commercialization. Through enhancing androgen receptor protein degradation, ASC-J9(TM) ... effect of androgens (male hormones), through the androgen receptor, a key causative factor in the ... mechanism of action, which selectively enhances androgen receptor degradation (ARD) to ...Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
... Findings suggest androgen production occurs within metastatic prostate ... found that despite the suppression of circulating androgen levels to very low or castrate levels, metastatic ... prostate tissue in men with normal circulating androgen levels (collected at the time of ...Study reveals a reprogrammed role for the androgen receptor
... BOSTONThe androgen receptor a protein ignition switch for prostate ... When drug therapy deprives the receptor of androgen hormones, thereby halting cell proliferation, the ... cell growth occurs, in part, because the androgen receptor switches on an entirely different set of ...3-D research model tackles prostate cancer spread
... removal surgery should have low levels of androgen and the cancer cells should be suppressed. ... fact that the cancer cells are very sensitive to androgen and even low levels of androgen in the body could promote the growth of these ...New drug shows promise in treating drug-resistant prostate cancer
... compounds, MDV3100 and RD162, which block the androgen receptor (AR) in CRPC cells, and report results ... was "designed as a very strong antagonist of the androgen receptor to stop the growth of any prostate ... cancer cells begin to increase production of the androgen receptor, Sawyers said. When the level ...New medications show promise in treating drug-resistant prostate cancer
... cancer cells begin to increase production of the androgen receptor, said Sawyers. When the level of androgen receptors on the cells' surface reaches a certain ... scientists have questioned whether blocking the androgen receptor is a wise course of action. But Sawyers ...Why a common treatment for prostate cancer ultimately fails
... help explain the process by showing that the androgen receptor, through which male hormones like ... in men. Understanding the effects of the androgen receptor gives physicians a toehold in efforts to ... One form of hormone therapy works by blocking the androgen ....Important new hair-loss gene discovered
... in hair-loss. "In one of these conspicuous regions lies the gene for the androgen receptor", Dr. Axel Hillmer of the Life&Brain Forschungszentrum (research ... inheritance of baldness in that hitherto the only known risk gene for the androgen receptor lay on the X-chromosome, and was thus inherited from the mother ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
... (IMRT) II-43 Benefits of IMRT II-44 Drawbacks of IMRT II-44 androgen Deprivation Therapy (ADT) II-44 High Dose Radiation (HDR) Monotherapy ... Therapeutics Reveals Phase 2 Clinical Trial Results of XYOTAX(TM) in androgen Independent Prostate Cancer Patients II-56 Sanofi-Aventis' Taxotere(R) ...Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
... novel cancer drug candidates from Santaris Pharma and Enzon has announced the targets for four of these compounds: Her3, beta catenin, PIK3CA and the androgen receptor. Pipeline Summary In H1 2009 Santaris Pharma continued the progress for both the drug discovery programs and the drug ...Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
... Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Casodex(R) tablets. Bicalutamide tablets are an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 ...PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
Description:... The PolarScreen androgen Receptor (AR) Competitor Assay Kits provide a ... (His-GST)], and a novel, selective fluorescent androgen ligand (Fluormone AL Green in the green assay kit ... compounds for AR-LBD (His-GST). The PolarScreen androgen Receptor Competitor Assay Kits include purified, ...